4+ hour, 53+ min ago  (589+ words) A decision for the supplemental Biologics License Application for Gazyva (obinutuzumab) to treat systemic lupus erythematosus is expected by December By Jonathan D. Grinstein, Ph D SLE is not a single-pathway disease. It is a systemic autoimmune condition in which the…...

12+ hour, 46+ min ago  (20+ words) The rheumatoid arthritis clinical trial analysis report delivers important insights into ongoing research of 80+ pipeline rheumatoid arthritis drugs, clinical. .....

1+ day, 2+ hour ago  (342+ words) Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living The Rheumatology Awareness Walkathon 2026 was organised across multiple cities in India on April 26, bringing together patients, clinicians, and caregivers in a nationwide effort to raise awareness…...

18+ hour, 26+ min ago  (218+ words) Lupus affects young women at crucial stages of their lives, and meaningful advances in treatment have been slow to'emerge. 1, 2'In2025, Biogen took an important step forward in lupus research by completing enrollment (last patient in) for the TOPAZ-1 and TOPAZ-2 Phase3 trials…...

15+ hour, 59+ min ago  (179+ words) Apr 28, 2026, 09: 47 ET Six recipients were selected for their novel projects that will help improve lupus diagnosis and treatment NEW YORK, April 28, 2026 /PRNewswire/ --Today, the Lupus Research Alliance (LRA), the world's largest private funder of lupus research, announced the six newest…...

14+ hour, 28+ min ago  (301+ words) Conexiant The US Food and Drug Administration has approved anifrolumab (Saphnelo) for subcutaneous self-administration using a once-weekly autoinjector in adult patients with systemic lupus erythematosus receiving standard therapy, providing an alternative to intravenous administration The approval was supported by results…...

17+ hour, 50+ min ago  (58+ words) The FDA has approved a self-administered autoinjector form of anifrolumab for the treatment of systemic lupus erythematosus, according to press release from the manufacturer. The anifrolumab (Saphnelo, Astra Zeneca) autoinjector, dubbed the Saphnelo Pen, has been approved for once-weekly use…...

21+ hour, 46+ min ago  (970+ words) A revolutionary cancer treatment is now being applied to a wide range of autoimmune disorders. Columnist Michael Le Page finds it is proving to be even more effective than expected Illustration of T-cells attacking a growing cancer cell Our immune…...

1+ day, 17+ hour ago  (281+ words) Priority Review is granted to medicines that may offer significant improvements in safety or effectiveness for serious conditions like warm autoimmune. .....

23+ hour, 29+ min ago  (521+ words) Experts view Sail's in vivo CAR-T therapy as a groundbreaking advancement with the potential to revolutionize autoimmune disease treatment by offering a single, curative solution instead of lifelong symptom management. "The power of In Vivo CAR-T for curative treatments in…...